McGee Aaron W, Strittmatter Stephen M
Departments of Neurology and Neurobiology, Yale University School of Medicine, PO Box 208018, New Haven, CT 06520, USA.
Trends Neurosci. 2003 Apr;26(4):193-8. doi: 10.1016/S0166-2236(03)00062-6.
CNS myelin inhibits axonal outgrowth in vitro and is one of several obstacles to functional recovery following spinal cord injury. Central to our current understanding of myelin-mediated inhibition are the membrane protein Nogo and the Nogo-66 receptor (NgR). New findings implicate NgR as a point of convergence in signal transduction for several myelin-associated inhibitors. Additional studies have identified a potential coreceptor for NgR as p75(NTR), and a second-messenger pathway involving RhoA that inhibits neurite elongation. Although these findings expand our understanding of the molecular determinants of adult CNS axonal regrowth, the physiological roles of myelin-associated inhibitors in the intact adult CNS remain ill-defined.
中枢神经系统髓磷脂在体外抑制轴突生长,是脊髓损伤后功能恢复的若干障碍之一。我们目前对髓磷脂介导的抑制作用的理解核心是膜蛋白Nogo和Nogo-66受体(NgR)。新的研究结果表明,NgR是几种髓磷脂相关抑制剂信号转导的汇聚点。进一步的研究确定了NgR的潜在共受体为p75(神经营养因子受体),以及一条涉及RhoA的第二信使途径,该途径抑制神经突伸长。尽管这些发现扩展了我们对成年中枢神经系统轴突再生分子决定因素的理解,但髓磷脂相关抑制剂在完整成年中枢神经系统中的生理作用仍不明确。